That would need to be proved. Many agents in theory can target all cancers.
Let us take Keytruda as an example. Merck has been spending billions over decades to run hundreds of trials to expand the indication into other cancers.
Many oncology agents being advanced potentially target all cancers. That does not mean they actually do.